The Latest on the Intracept Procedure
Relievant Announces Publication of Positive Results from Multi-Center Study of the Intracept® Procedure in Real-world Setting for Patients with Chronic Low Back Pain
Relievant Medsystems, a privately-held medical device company transforming the treatment of Chronic Low Back Pain (CLBP), today announced the publication of significant and clinically-meaningful outcomes from a prospective, open-label, single-arm, multi-center study in the European Spine Journal…
Relievant Announces Publication of Level l INTRACEPT Study
Relievant Medsystems, a privately-held medical device company focused on transforming the treatment of Chronic Low Back Pain (CLBP), today announced the publication of the Level I INTRACEPT Study results in The Spine Journal. The INTRACEPT Study is a Level I,...
Relievant Announces Publication of SMART Trial 24-Month Results
Relievant Medsystems, a privately-held medical device company developing minimally-invasive solutions for chronic low back pain (CLBP), today announced the publication of 24-month results from the SMART trial in the International Journal of Spine Surgery. A total of...
American Society of Spine Radiology Announces the Presentation of Results From the Level l INTRACEPT Study
Results from the pre-specified interim analysis of the landmark INTRACEPT randomized controlled trial were presented for first time on February 20, 2019 at the American Society of Spine Radiology (ASSR) meeting in Miami, Fla. The study demonstrated statistically and...
Relievant Announces Level l INTRACEPT Study Stopped Early for Superiority
Relievant Medsystems, a privately-held medical device company, developing minimally-invasive solutions for chronic low back pain (CLBP), today announced that a pre-specified interim analysis of the Level I INTRACEPT Randomized Controlled Trial (RCT) found a highly...
Relievant Announces Reimbursement Codes and APC Assignment for The Intracept® Procedure
Relievant Medsystems, a privately-held medical device company developing minimally-invasive solutions for chronic low back pain (CLBP), today announced that the Centers for Medicare & Medicaid Services (CMS) has established Healthcare Common Procedure Coding...
Relievant Announces First Commercial Intracept Procedures
Relievant Medsystems, a privately-held medical device company developing minimally-invasive solutions for chronic low back pain (CLBP), announced today the successful completion of the first commercial Intracept Procedures. The procedures were performed by Dr. Bradly...
Relievant Announces Completion of $58M Series E Financing to Support US Commercialization
Relievant Medsystems, a privately-held medical device company developing minimally-invasive solutions for chronic low back pain (CLBP), announced today the completion of a $58 million equity financing. The round was led by Endeavour Vision and included participation...
Relievant Appoints Christopher Geyen Chief Financial Officer
Relievant Medsystems, a privately held medical device company that has developed the Intracept® Procedure, a minimally invasive and clinically proven approach for the treatment of chronic low back pain, announced today the appointment of Christopher Geyen as Chief...
Relievant Announces Publication of Positive Outcomes in 12-Month SMART Sham RCT
Relievant Medsystems, a privately held medical device company that developed the Intracept® Procedure, a minimally invasive and clinically proven approach for the treatment of chronic low back pain (CLBP), announced today the publication of the pivotal SMART Trial...